XAV-939, 98%, a selective Wnt pathway beta-catenin-mediated transcription inhibitor - 100MG 100mg

名称与同义词

• XAV-939
• XAV939
• 284028-89-3
• XAV 939
• NVP-XAV 939
• 3kr8
• 3uh4
• 3,5,7,8-Tetrahydro-2-[4-(trifluoromethyl)phenyl]-4H-thiopyrano[4,3-d]pyrimidin-4-one
• AC1MBK2K
• Maybridge3_005018
• RefChem:195217
• C14H11F3N2OS
• CHEBI:62878
• G2MY39VR77
• NVP-XAV939
• CHEMBL1086580
• XAV-939 (GMP)
• cc-343
• MLS006012021
• NVP-XAV-939
• DTXSID60369423
• KLGQSVMIPOVQAX-UHFFFAOYSA-N
• MFCD16879017
• orb1307281
• SCHEMBL7783488
• TB3748-GMP
• SCHEMBL15315468
• SCHEMBL15565864
• SCHEMBL29411302
• AOB4150
• DTXCID20320459
• XAV939,XAV-939
• BCPP000009
• GLXC-03267
• HMS1445E02
• HMS3414D07
• HMS3648B17
• HMS3654O16
• HMS3678D07
• HMS3743E05
• XAV939, XAV-939
• BCP02128
• EX-A1760
• XAV-939?
• CID 2726824
• ABP000288
• BDBM50188594
• BDBM50318567
• EBC-11320
• EBC-84065
• HB0660
• HY-15147G
• MFCD00106866
• MFCD24369740
• NSC755761
• s1180
• ZINC00077297
• ZINC13467799
• AKOS015954858
• AKOS024457786
• AKOS026750243
• CCG-208105
• CID2726824
• CS-0494
• FX28737
• NSC-755761
• RL02965
• SB19432
• XAV 939; NVP-XAV 939;
• IDI1_016405
• KS-0000181U
• NCGC00250397-01
• NCGC00484998-01
• 2-[4-(trifluoromethyl)phenyl]-1,5,7,8-tetrahydrothiopyrano[4,3-d]pyrimidin-4-one
• AC-28393
• AK198691
• AN-16908
• CS-10386
• HY-15147
• SC-95571
• SMR003874205
• XAV 939/XAV939,NVP-XAV939
• XAV939, >=98% (HPLC)
• CID:135418940
• SID:181285835
• DB-067924
• A1877
• CS-0615627
• FT-0675873
• SW218311-2
• X0077
• X7558
• J1.472.399D
• A10994
• A25698
• W-5666
• 2-(4-(trifluoromethyl)phenyl)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-4-ol
• EN300-6732792
• C544261
• SR-01000946403
• SR-01000946403-1
• BRD-K12762134-001-01-3
• BRD-K12762134-001-05-4
• BRD-K12762134-001-06-2
• BRD-K12762134-001-07-0
• Q27132250
• 2-[4-(trifluoromethyl)phenyl]-5H,7H,8H-thiopyrano[4,3-d]pyrimidin-4-ol
• 2-[4-(trifluoromethyl)phenyl]-7,8-dihydro-5H-thiino[4,3-d]pyrimidin-4-ol
• 2-[4-(Trifluoromethyl)phenyl]-7,8-Dihydro-5h-Thiopyrano[4,3-D]pyrimidin-4-Ol
• Z2235801832
• B0084-212112
• 2-(4-(Trifluoromethyl)phenyl)-3,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one
• 2-(4-(trifluoromethyl)phenyl)-7,8-dihydro-3H-thiopyrano[4,3-d]pyrimidin-4(5H)-one
• 2-[4-(trifluoromethyl)phenyl]-3H,4H,5H,7H,8H-thiopyrano[4,3-d]pyrimidin-4-one
• 2-[4-(trifluoromethyl)phenyl]-6,8-dihydro-5H-thiopyrano[3,4-d]pyrimidine
• 6,8-Dihydro-2-[4-(trifluoromethyl)phenyl]-5H-thiopyrano[3,4-d]pyrimidine
• 1,5,7,8-Tetrahydro-2-[4-(trifluoromethyl)phenyl]-4H-thiopyrano[4,3-d]pyrimidin-4-one
• 2-(4-(trifluoromethyl)phenyl)-1,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one
• 2-(4-(trifluoromethyl)phenyl)-7,8-dihydro-1H-thiopyrano[4,3-d]pyrimidin-4(5H)-one
• 2-(4-(Trifluoromethyl)phenyl)-7,8-dihydro-5H-thiopyrano(4,3-d)pyrimidin-4-ol
• 2-(4-(Trifluoromethyl)phenyl)-7,8-dihydro-5H-thiopyrano-[4,3-d]pyrimidin-4-ol
• 2-(4-Trifluoromethylphenyl)-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine-4(3H)-one
• 2-[4-(Trifluoromethyl)phenyl]-1,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one
• 2-[4-(trifluoromethyl)phenyl]-1H,4H,5H,7H,8H-thiopyrano[4,3-d]pyrimidin-4-one
• 2-[4-(TRIFLUOROMETHYL)PHENYL]-1H,5H,7H,8H-THIOPYRANO[4,3-D]PYRIMIDIN-4-ONE
• 2-[4-(trifluoromethyl)phenyl]-3,5,7,8-tetrahydrothiopyrano[4,3-d]pyrimidin-4-one
• 2-[4-(TRIFLUOROMETHYL)PHENYL]-3H,5H,7H,8H-THIOPYRANO[4,3-D]PYRIMIDIN-4-ONE
• 2-[4-(Trifluoromethyl)phenyl]-4-hydroxy-5,6,7,8-tetrahydro-6-thiaquinazoline
• 2-[4-(Trifluoromethyl)phenyl]-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine-4(3H)-one
• 3,5,7,8-Tetrahydro-2-(4-(trifluoromethyl)phenyl)-4H-thiopyrano(4,3-d)pyrimidin-4-one
• 4H-Thiopyrano[4,3-d]pyrimidin-4-one, 3,5,7,8-tetrahydro-2-[4-(trifluoromethyl)phenyl]-
• 4H-Thiopyrano[4,3-d]pyrimidin-4-one, 3,5,7,8-tetrahydro-2-[4-(trifluoromethyl)phenyl]-?
• 3,5,7,8-TETRAHYDRO-2-[4-(TRIFLUOROMETHYL)PHENYL]-4H-THIOPYRANO[4,3-D]PYRIMIDIN-4-OL
• 687-302-1
• XAV
• XAV-939, 98%, a selective Wnt pathway beta-catenin-mediated transcription inhibitor - 100MG 100mg